Skip to main content
. 2020 Dec 16;35(3):140–146. doi: 10.1007/s40211-020-00380-8

Table 3.

Levels of FGF21 (pg/ml) in groups with ALC (n = 41), NALC (n = 34) and healthy controls (n = 21) according to self-reported drinking behaviour and ETG levels

Groups Alcohol consumption n (%) Mean (SD) Median (IQR) p-value (U-test)
ALC Self-reported alcohol consumption Positive 5 (12) 471 (624) 156 (359)
Negative 36 (88) 494 (710) 275 (348) 0.5744
ETG levels Positive 9 (22) 1056 (1216) 589 (1056)
Negative 32 (78) 333 (347) 213 (216) 0.0441*
NALC Self-reported alcohol consumption Positive 7 (21) 322 (293) 247 (289)
Negative 27 (79) 317 (511) 183 (240) 0.5877
ETG levels Positive 4 (12) 490 (284) 431 (377)
Negative 30 (88) 296 (489) 182 (182) 0.0263*
Controls Self-reported alcohol consumption Positive 13 (67) 303 (216) 271 (236)
Negative 7 (33) 306 (247) 261 (329) 0.8773
ETG levels Positive 0 (0)
Negative 21 (100) 299 (217) 261 (239)

Positive self-reported alcohol consumption 0.5 unit/week or more (1 unit alcohol was one beer (0.5 l), one glass of wine (0.25 l) or one shot (4 cl), e.g. 20 g pure alcohol/unit)

Negative self-reported alcohol consumption less than 0.5 unit/week

Positive ETG level >0.5 μg/ml

Negative ETG level <0.5 μg/ml

ALC alcoholic liver cirrhosis, NALC nonalcoholic liver cirrhosis, IQR interquartile range, ETG ethyl glucuronide, SD standard deviation, FGF21 fibroblast growth factor 21

* significance p < 0.05